Successful Intermittent Chemoprophylaxis for Pneumocystis carinii Pneumonitis

New England Journal of Medicine

Volumn 316, Issue 26, 1987, Pages 1627-1632

  Hughes, Walter T ^a   Rivera, Gaston K ^a   Schell, Michael J ^a   Thornton, Delaine ^a   Lott, Lennie ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PENTAMIDINE ISETHIONATE; PREDNISONE; SULFAMETHOXAZOLE; TENIPOSIDE; TREHALOSE; TRIMETHOPRIM; VINCRISTINE;

ABDOMINAL PAIN; ACUTE LYMPHOCYTIC LEUKEMIA; ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG MIXTURE; DRUG THERAPY; HUMAN; INTOXICATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MICROORGANISM; MUCOSA INFLAMMATION; MYCOSIS; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PNEUMONIA; PREVENTION; PRIORITY JOURNAL; RASH; RESPIRATORY SYSTEM; SKIN TOXICITY; SUPERINFECTION; THERAPY;

EID: 0023258601     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198706253162604     Document Type: Article

References (23)

1. Hughes WT, McNabb PC, Makres TD, Feldman S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother 1974; 5: 289–93.
2. Hughes WT. Limited effect of trimethoprim–sulfamethoxazole prophylaxis on Pneumocystis carinii. Antimicrob Agents Chemother 1979; 16: 333–5.
3. Kluge RN, Spaulding DM, Spain AJ. Combination of pentamidine and trimethoprim–sulfamethoxazole in the therapy of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 1978; 13: 975–8.
4. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297: 1419–26.
5. Wilber RB, Feldman S, Malone WJ, Ryan M, Aur RJA, Hughes WT. Chemoprophylaxis for Pneumocystis carinii pneumonitis: outcome of unstructured delivery. Am J Dis Child 1980; 134: 643–8.
6. Hughes WT. Five-year absence of Pneumocystis carinii pneumonitis in a pediatric oncology center. J Infect Dis 1984; 150: 305–6.
7. Harris RE, McCallister JA, Allen SA, Barton AS, Baehner RL. Prevention of Pneumocystis pneumonia: use of continuous sulfamethoxazole-trimethoprim therapy. Am J Dis Child 1980; 134: 35–8.
8. Chusid MJ, Heyrman KA. An outbreak of Pneumocystis carinii pneumonia at a pediatric hospital. Pediatrics 1978; 62: 1031–5.
9. Jick H. Adverse reactions to trimethoprim–sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982; 4: 426–8.
10. Asmar BI, Maqbool S, Dajani AS. Hematologic abnormalities after oral trimethoprim–sulfamethoxazole therapy in children. Am J Dis Child 1980; 135: 1100–3.
11. Jaffe HS, Abrams DI, Ammann AJ, Lewis BJ, Golden JA. Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet 1983; 2: 1109–11.
12. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim–sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 495–9.
13. Mitsuyasu R, Groopman J, Volberding P. Cutaneous reaction to trimethoprim–sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med 1983; 308: 1535–6.
14. Small CB, Harris CA, Friedland GH, Klein RS. The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch Intern Med 1985; 145: 837–40.
15. Pifer LL, Hughes WT, Murphy MJ Jr. Propagation of Pneumocystis carinii in vitro. Pediatr Res 1977; 11: 305–16.
16. Hughes WT, Smith BL. Intermittent chemoprophylaxis for Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 1983; 24: 300–1.
17. Rivera GK, George SL, Williams D, et al. Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemia. Med Pediatr Oncol 1986; 14: 177–81.
18. Gualtieri RJ, Donowitz GR, Kaiser DL, Hess CE, Sande MA. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. Am J Med 1983; 74: 934–40.
19. Kaufman CA, Liepman MK, Bergman AG, Mioduszewski J. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients: reduction of infections and effect on bacterial and fungal flora. Am J Med 1983; 74: 599–607.
20. Pizzo PA, Robichand KJ, Edwards BK, Schumaker C, Kramer BS, Johnson A. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr 1983; 102: 125–33.
21. de Jongh CA, Wade JC, Finley RS, et al. Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung. J Clin Oncol 1983; 1: 302–7.
22. Goorin AM, Hershey BJ, Levin MJ, et al. Use of trimethoprim–sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia. Pediatr Infect Dis 1985; 4: 265–9.
23. Kovatch AL, Wald ER, Albo VC, et al. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children. Pediatrics 1985; 76: 754–60.